The National Comprehensive Cancer Network (NCCN) recommends a BRCA2 genetic test starting at age 40 years in cases of a personal history of metastatic, node-positive, biochemically recurrent, Gleason ≥8, or Gleason 7 disease with a strong family history of BRCA-related cancers. Here, BRCA2 is linked to cancer.